FDA
approval
· 2024-09-19
FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved Camber Pharmaceuticals' supplemental application for a generic Lamivudine and Zidovudine fixed-dose combination, expanding access to this HIV t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)